Little Green Pharma Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.36%

Little Green Pharma Ltd (LGP) has an Asset Resilience Ratio of 2.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Little Green Pharma Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$2.30 Million
≈ $1.63 Million USD Cash + Short-term Investments

Total Assets

AU$97.60 Million
≈ $69.06 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Little Green Pharma Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Little Green Pharma Ltd (LGP) total assets.

Liquid Assets Composition Over Time

This chart breaks down Little Green Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Little Green Pharma Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$2.30 Million 2.36%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$2.30 Million 2.36%

Asset Resilience Insights

  • Limited Liquidity: Little Green Pharma Ltd maintains only 2.36% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Little Green Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Little Green Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Yunnan Baiyao Group Co Ltd
SHE:000538
Drug Manufacturers - Specialty & Generic 8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Jiuzhitang Co Ltd
SHE:000989
Drug Manufacturers - Specialty & Generic 7.86%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for Little Green Pharma Ltd (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Little Green Pharma Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 2.47% AU$2.38 Million
≈ $1.68 Million
AU$96.12 Million
≈ $68.01 Million
-3.29pp
2024-06-30 5.76% AU$4.97 Million
≈ $3.52 Million
AU$86.38 Million
≈ $61.12 Million
-6.82pp
2023-06-30 12.57% AU$12.40 Million
≈ $8.77 Million
AU$98.62 Million
≈ $69.78 Million
-8.36pp
2022-06-30 20.94% AU$20.09 Million
≈ $14.21 Million
AU$95.95 Million
≈ $67.89 Million
-15.35pp
2021-06-30 36.28% AU$40.27 Million
≈ $28.49 Million
AU$110.99 Million
≈ $78.53 Million
+10.23pp
2020-06-30 26.05% AU$4.27 Million
≈ $3.02 Million
AU$16.40 Million
≈ $11.61 Million
+22.77pp
2019-06-30 3.28% AU$510.29K
≈ $361.06K
AU$15.57 Million
≈ $11.01 Million
-33.38pp
2018-06-30 36.65% AU$1.47 Million
≈ $1.04 Million
AU$4.02 Million
≈ $2.85 Million
--
pp = percentage points

About Little Green Pharma Ltd

AU:LGP Australia Drug Manufacturers - Specialty & Generic
Market Cap
$15.80 Million
AU$22.33 Million AUD
Market Cap Rank
#25926 Global
#1144 in Australia
Share Price
AU$0.07
Change (1 day)
+7.35%
52-Week Range
AU$0.06 - AU$0.14
All Time High
AU$0.94
About

Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.